Focused pseudostatic hydrazone libraries screened by mass spectrometry binding assay: optimizing affinities toward γ-aminobutyric acid transporter 1.

Mass spectrometric (MS) binding assays, a powerful tool to determine affinities of single drug candidates toward chosen targets, were recently demonstrated to be suitable for the screening of compound libraries generated with reactions of dynamic combinatorial chemistry when rendering libraries pseudostatic. Screening of small hydrazone libraries targeting γ-aminobutyric acid transporter 1 (GAT1), the most abundant γ-aminobutyric acid (GABA) transporter in the central nervous system, revealed two nipecotic acid derived binders with submicromolar affinities. Starting from the biphenyl carrying hit as lead structure, the objective of the present study was to discover novel high affinity GAT1 binders by screening of biphenyl focused pseudostatic hydrazone libraries formed from hydrazine 10 and 36 biphenylcarbaldehydes 11c-al. Hydrazone 12z that carried a 2',4'-dichlorobiphenyl residue was found to be the most potent binder with low nanomolar affinity (pK(i) = 8.094 ± 0.098). When stable carba analogues of representative hydrazones were synthesized and evaluated, the best binder 13z was again displaying the 2',4'-dichlorobiphenyl moiety (pK(i) = 6.930 ± 0.021).

[1]  D. Dolenc,et al.  Autoxidation of hydrazones. Some new insights. , 2007, The Journal of organic chemistry.

[2]  P. Suzdak,et al.  Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives. , 2001, Bioorganic & medicinal chemistry.

[3]  R. Larock,et al.  An aryl to imidoyl palladium migration process involving intramolecular C-H activation. , 2007, Journal of the American Chemical Society.

[4]  K. Wanner,et al.  Library Screening by Means of Mass Spectrometry (MS) Binding Assays—Exemplarily Demonstrated for a Pseudostatic Library Addressing γ‐Aminobutyric Acid (GABA) Transporter 1 (GAT1) , 2012, ChemMedChem.

[5]  P. Suzdak,et al.  (R)‐N‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier , 1990, Journal of neurochemistry.

[6]  W. Löscher,et al.  Influence of inhibitors of the high affinity GABA uptake on seizure thresholds in mice , 1979, Neuropharmacology.

[7]  N. O. Dalby.  GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors , 2000, Neuropharmacology.

[8]  H. Yao,et al.  Azo—Hydrazone Conversion. III. The Autoxidation of Benzaldehyde Phenylhydrazones , 1965 .

[9]  H. Irngartinger,et al.  Strong electron acceptor properties of 3′(pentafluorophenyl)isoxazolo[4′,5′:1,2][60]fullerene derivatives , 1999 .

[10]  A. B. Pizzo,et al.  Pharmacological and Biochemical Aspects of GABAergic Neurotransmission: Pathological and Neuropsychobiological Relationships , 2004, Cellular and Molecular Neurobiology.

[11]  C. Kaiser,et al.  Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake , 1985 .

[12]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[13]  G. Nowak,et al.  GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. , 2005, Drugs of today.

[14]  D. Treiman.  GABAergic Mechanisms in Epilepsy , 2001, Epilepsia.

[15]  L. Iversen,et al.  GABA UPTAKE IN RAT CENTRAL NERVOUS SYSTEM: COMPARISON OF UPTAKE IN SLICES AND HOMOGENATES AND THE EFFECTS OF SOME INHIBITORS , 1971, Journal of neurochemistry.

[16]  N. Bowery,et al.  GABA and glycine as neurotransmitters: a brief history , 2006, British journal of pharmacology.

[17]  M. Neal,et al.  THE UPTAKE OF [3H]GABA BY SLICES OF RAT CEREBRAL CORTEX , 1968, Journal of neurochemistry.

[18]  K. Wanner,et al.  Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4. , 2008, European journal of medicinal chemistry.

[19]  P. Krogsgaard‐Larsen,et al.  INHIBITION OF GABA UPTAKE IN RAT BRAIN SLICES BY NIPECOTIC ACID, VARIOUS ISOXAZOLES AND RELATED COMPOUNDS , 1975, Journal of neurochemistry.

[20]  G. Spincemaille,et al.  Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy , 2008, Neuroscience Letters.

[21]  D. Rusakov,et al.  Deletion of the betaine–GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice , 2011, Epilepsy Research.

[22]  A. Schousboe,et al.  Synaptic and extrasynaptic GABA transporters as targets for anti‐epileptic drugs , 2009, Journal of neurochemistry.

[23]  Arnold R. Kriegstein,et al.  Is there more to gaba than synaptic inhibition? , 2002, Nature Reviews Neuroscience.

[24]  P. Klivényi,et al.  Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease , 2009, Pharmacology Biochemistry and Behavior.

[25]  T. Librowski,et al.  A role of GABA analogues in the treatment of neurological diseases. , 2010, Current medicinal chemistry.

[26]  P. O'Brien,et al.  Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model. , 2008, Toxicology and applied pharmacology.

[27]  G F Mason,et al.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments , 2002, Molecular Psychiatry.

[28]  A. Schousboe,et al.  GABA uptake inhibitors: relevance to antiepileptic drug research , 1987, Epilepsy Research.

[29]  T. Ema,et al.  Suzuki-Miyaura coupling reaction using pentafluorophenylboronic acid. , 2005, Organic letters.

[30]  U. Gether,et al.  SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation , 2011, Pharmacological Reviews.

[31]  J. Smith,et al.  Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. , 1969, Annals of internal medicine.

[32]  Abraham Weizman,et al.  BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia , 2009, European Neuropsychopharmacology.

[33]  John D. Salamone,et al.  The GABA uptake inhibitor β-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis , 2004, Journal of Neuroscience Methods.

[34]  M. Busch,et al.  Autoxydation der Hydrazone , 1914 .

[35]  K. Wanner,et al.  Expanding the scope of MS binding assays to low-affinity markers as exemplified for mGAT1 , 2008, Analytical and bioanalytical chemistry.

[36]  K. Wanner,et al.  Deletion of the γ-Aminobutyric Acid Transporter 2 (GAT2 and SLC6A13) Gene in Mice Leads to Changes in Liver and Brain Taurine Contents* , 2012, The Journal of Biological Chemistry.

[37]  Spencer J. Williams,et al.  Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates. , 2009, Bioorganic & medicinal chemistry letters.

[38]  K. Wanner,et al.  MS Binding Assays – An Alternative to Radioligand Binding , 2007 .

[39]  P. Suzdak,et al.  Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates. , 1999, Journal of medicinal chemistry.

[40]  T. Branchek,et al.  Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. , 1994, European journal of pharmacology.

[41]  Yanong Wang,et al.  Zr-Mediated hydroboration: stereoselective synthesis of vinyl boronic esters , 2005 .

[42]  Ronald T Raines,et al.  Hydrolytic stability of hydrazones and oximes. , 2008, Angewandte Chemie.

[43]  K. Wanner,et al.  MS‐Binding Assays: Kinetic, Saturation, and Competitive Experiments Based on Quantitation of Bound Marker as Exemplified by the GABA Transporter mGAT1 , 2006, ChemMedChem.

[44]  T. Aoyagi,et al.  Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease. , 1990, Chemical and pharmaceutical bulletin.